​

Zura Bio Ownership | Who Owns Zura Bio?

OverviewForecastFinancialsChart

Zura Bio Ownership Summary

Zura Bio is owned by 17.45% institutional investors, 24.49% insiders, and 58.06% retail investors. Suvretta capital management is the largest institutional shareholder, holding 9.63% of ZURA shares.

ZURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockZura Bio17.45%24.49%58.06%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Suvretta capital management9.07M9.63%$53.95M
Vr adviser6.43M6.83%$38.29M
Jpmorgan chase4.46M4.74%$25.33M
Great point partners4.22M4.48%$25.08M
Braidwell lp3.99M4.24%$23.73M
Siren3.73M3.97%$22.22M
Commodore capital lp3.25M3.45%$19.34M
Pfizer2.84M3.02%$16.83M
Adage capital partners gp2.75M2.92%$16.36M
Affinity asset advisors2.56M2.72%$15.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pfizer2.84M7.05%$16.83M
Great point partners4.22M5.77%$25.08M
Vr adviser6.43M1.43%$38.29M
Suvretta capital management9.07M1.38%$53.95M
Commodore capital lp3.25M1.12%$19.34M
Stempoint capital lp753.52K0.87%$4.48M
Saturn v capital management739.96K0.80%$4.40M
Braidwell lp3.99M0.79%$23.73M
Affinity asset advisors2.56M0.79%$15.26M
Boxer capital management900.00K0.70%$5.36M

Top Buyers

HolderShares% AssetsChange
Suvretta capital management9.07M1.38%3.50M
Commodore capital lp3.25M1.12%3.25M
Siren3.73M0.62%2.43M
Cormorant asset management, lp1.45M0.43%1.45M
Qvt financial lp1.31M0.57%1.31M

Top Sellers

HolderShares% AssetsChange
Ra capital management---3.22M
Allostery investments lp---2.33M
Morgan stanley872.95K0.00%-636.46K
Woodline partners lp---520.28K
Sphera funds management---421.23K

New Positions

HolderShares% AssetsChangeValue
Commodore capital lp3.25M1.12%3.25M$19.34M
Cormorant asset management, lp1.45M0.43%1.45M$8.63M
Qvt financial lp1.31M0.57%1.31M$7.80M
Ecor1 capital1.18M0.30%1.18M$7.02M
Stempoint capital lp753.52K0.87%753.52K$4.48M

Sold Out

HolderChange
Ifp advisors-14.00
Sterling capital management-53.00
True wealth design-78.00
Clearstead advisors-239.00
Wells fargo & company/mn-385.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202535-50.70%16,505,575-59.89%170.92%22-35.29%8-65.22%
Sep 30, 20256815.25%39,551,29314.18%411.49%33-2131.25%
Jun 30, 202562-17.33%35,347,572-22.51%542.25%3620.00%16-23.81%
Mar 31, 202575-18.48%45,725,3626.61%492.04%31-44.64%2190.91%
Dec 31, 2024929.52%42,888,90115.28%492.71%56-1.75%1137.50%

Recent Insider Transactions

DateNameRoleActivityValue
Feb 26, 2026AI Biotechnology LLC-Buy$12.50M
Oct 30, 2023Sidhu Someit-Buy$28.52M
Nov 25, 2024Thiara Parvinder-Sell$2.73M
Sep 11, 2024Thiara Parvinder-Sell$10.26M
Sep 04, 2024Sidhu Someit-Sell$200.19K

Insider Transactions Trends

DateBuySell
2026 Q2--
2026 Q11-
2025 Q4--
2025 Q3--
2025 Q2--

ZURA Ownership FAQ

Who Owns Zura Bio?

Zura Bio shareholders are primarily institutional investors at 17.45%, followed by 24.49% insiders and 58.06% retail investors. The average institutional ownership in Zura Bio's industry, Biotech Stocks , is 379.48%, which Zura Bio falls below.

Who owns the most shares of Zura Bio?

Zura Bio’s largest shareholders are Suvretta capital management (9.07M shares, 9.63%), Vr adviser (6.43M shares, 6.83%), and Jpmorgan chase (4.46M shares, 4.74%). Together, they hold 21.20% of Zura Bio’s total shares outstanding.

Does Blackrock own Zura Bio?

BlackRock is not among the top 10 institutional shareholders of Zura Bio.

Who is Zura Bio’s biggest shareholder by percentage of total assets invested?

Pfizer is Zura Bio’s biggest shareholder by percentage of total assets invested, with 7.05% of its assets in 2.84M Zura Bio shares, valued at 16.83M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools